GLP‑1 Marketing for Med Spas: Fix These Before Running Ads
Semaglutide, Tirzepatide and other GLP‑1 weight‑loss drugs are the hottest topic in aesthetics right now.
Clinics everywhere are trying to cash in, but most are running head‑first into regulatory landmines and sky‑high advertising costs.
The FDA recently sent 30 warning letters to telehealth companies marketing compounded GLP‑1s, alleging that their advertising was misleading. At the same time, patient acquisition costs on Meta and Google continue to climb. If you jump straight into advertising without fixing your offer, processes and follow‑up, you’ll burn through cash and potentially invite regulatory scrutiny.
This guide breaks down what to do before you spend a dollar on ads.
Why GLP‑1 Marketing Requires a New Approach
Rising competition and new regulations
The med spa industry in 2026 is in flux. Consumers are smarter, more digital‑first and more selective, while clinics face increased competition from national and virtual wellness brands. At the same time, states have tightened telehealth standards, requiring Good Faith Exams (GFEs), patient‑specific orders and legitimate provider–patient relationships. These changes mean that your marketing must integrate compliance from the start, not treat it as an afterthought.
Automation and retention matter more than ever
Modern med spa growth is powered by automation. Clinics that adopt full patient lifecycle automation—including smart lead capture forms, instant SMS follow‑ups, AI‑qualified consultations and post‑treatment reactivation campaigns—are growing 3‑5× faster, with 40–60% more repeat bookings. Without automated follow‑up, even the best ad campaigns will leak leads. Fixing your CRM, reminders and reactivation flows before advertising will dramatically improve ROI.
Compliance isn’t optional
On March 3, 2026 the FDA sent warning letters to 30 telehealth companies marketing compounded GLP‑1 products. The agency alleged that many telehealth firms were misbranding compounded drugs by using brand names like Wegovy and Ozempic and by making unapproved weight‑loss claims. Misleading statements implying that compounded products are equivalent to FDA‑approved drugs can render promotions illegal. For med spas this means you must avoid phrases like “generic Zepbound” or “Ozempic‑like” in your ads and website copy.
Build a Compliant and Conversion‑Ready Funnel
1. Structure your telehealth workflow
Regulators require a documented GFE before prescribing GLP‑1 drugs. Partner with a licensed telehealth provider or build your own workflow to capture patient information, conduct an asynchronous or live GFE and issue patient‑specific orders. Document the process to demonstrate compliance if the FDA or advertising platforms request proof.
2. Clarify product differentiation
Separate FDA‑approved products from compounded products in your marketing. Catalog every GLP‑1 offering and use clear language to indicate whether a drug is FDA‑approved or compounded. Avoid making claims about safety or efficacy for compounded versions, and never imply that they are equivalent to approved drugs. If you offer compounded medications, ensure that the compounding pharmacy meets 503A or 503B requirements and that any “shortage” justification is valid.
3. Fix your website and booking experience
Visitors who click on your ads should land on a page designed to convert. Include multiple contact options—phone, web form and online booking. Offer educational content about GLP‑1 therapy, eligibility, expectations and pricing. Use trust signals such as before‑and‑after photos (for FDA‑approved treatments), provider credentials and patient testimonials. Ensure the site loads quickly on mobile devices and passes Core Web Vitals; slow or outdated sites bleed conversions and raise advertising costs.
4. Automate lead capture and qualification
Use smart forms to collect relevant medical and lifestyle information up front. Integrate AI‑based qualification to route leads to the appropriate provider and send instant SMS or email confirmations. Abandoned booking automations should trigger reminders and follow‑up messages to recover lost opportunities. High‑intent leads should reach a scheduler or nurse within minutes; otherwise they will book elsewhere.
5. Build a retention calendar
GLP‑1 programs are long term. Plan 12‑month retention calendars with automated check‑ins, progress tracking, nutritional coaching and upsell flows (e.g., from weight loss to hormone therapy). Sending post‑treatment surveys and review requests not only builds loyalty but also improves your search visibility.
The mrktbsd Take
Too many med spa owners treat GLP‑1 like a gold rush. They throw money at Meta ads expecting a flood of consults, only to realize later that their call center isn’t staffed, their website confuses patients and their pharmacy partners aren’t compliant. At mrktbsd, we start by auditing your entire revenue funnel. We look at your telehealth protocols, CRM automation and creative. Only after the foundations are solid do we scale paid campaigns. We would rather turn away ad revenue than take on a client whose operations will get them shut down. Remember: marketing exposes weakness faster than it fixes it.
GLP‑1 marketing isn’t about shouting “weight loss” in every ad; it’s about building a compliant, automated patient journey that converts expensive clicks into lifelong clients. Fix your systems before you spend.
